Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that hair supplement ingredients may be unsafe and should be disclosed and proven safe before use.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Some epilepsy drugs can cause reproductive and cosmetic side effects in women and affect pregnancy, but most women still have healthy babies.

The commentary stresses the importance of using historical control data and proper interpretation in evaluating developmental toxicity.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Finasteride may affect fetal brain development and increase arousal, but more research is needed for safety confirmation.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Turkish pregnant women commonly experienced skin issues like itching and acne, and doctors mainly used topical treatments due to safety concerns during pregnancy.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

Some congenital hair disorders improve in childhood or with treatments like minoxidil and retinoids, while others like Netherton syndrome and trichothiodystrophy have a poor prognosis.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

The manuscript "Strīvilāsa" offers ancient Ayurvedic knowledge on women's health, beauty treatments, and reproductive care.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Experts discussed treatments for skin conditions in children, emphasizing hydration, cautious medication use, and early intervention for infections.

Taking biotin supplements can be risky and often lacks evidence of effectiveness for skin, hair, and nail issues.

Some skin, hair, and nail supplements can be toxic, interact with medications, affect lab tests, and may increase cancer risk.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

Three specific genetic variants cause severe skin issues in children with EBS, highlighting the need for early genetic screening.